首页> 美国卫生研究院文献>Medical Science Monitor : International Medical Journal of Experimental and Clinical Research >The Utility of Thyroid Transcription Factor 1 (TTF-1) Napsin A Excision Repair Cross-Complementing 1 (ERCC1) Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma – A Retrograde Single-Center Study from Croatia

【2h】

The Utility of Thyroid Transcription Factor 1 (TTF-1) Napsin A Excision Repair Cross-Complementing 1 (ERCC1) Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma – A Retrograde Single-Center Study from Croatia

机译：甲状腺转录因子1（TTF-1）餐巾纸A切除修复交叉互补1（ERCC1）间变性淋巴瘤激酶（ALK）和表皮生长因子受体（EGFR）在小肠穿刺活检中的表达对预后的影响肺腺癌–来自克罗地亚的逆行单中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundThe present study was carried out in order to evaluate our institutional experience with small biopsy in diagnosis and molecular testing of lung adenocarcinoma. Few specific and predictive markers have been evaluated and correlated with clinicopathologic characteristics and survival in patients with lung adenocarcinoma who received platinum-based chemotherapy. There have not been such reports from Croatia.

机译：背景本研究旨在评估我们的小肺活检在肺腺癌的诊断和分子检测方面的机构经验。接受铂类化学疗法治疗的肺腺癌患者中很少有特异性和预测性标志物与临床病理特征和生存相关。克罗地亚没有这样的报道。

著录项

期刊名称 Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
作者
Marina Piljić Burazer; Suzana Mladinov; Vesna Ćapkun; Sendi Kuret; Merica Glavina Durdov;
展开▼
作者单位

展开▼
年(卷),期 2017(23),-1
年度 2017
页码 489–497
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
Carcinoma Non-Small-Cell Lung; Diagnosis; Immunohistochemistry; Pathology; Prognosis; Real-Time Polymerase Chain Reaction;

机译：癌;非小细胞肺癌;诊断;免疫组织化学;病理;预后实时聚合酶链反应;

相似文献

外文文献
中文文献
专利

1. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report [J] . Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, BMC research notes . 2013,第1期

机译：对克唑替尼具有耐药性的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变
2. Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma [J] . Rina Na, Wei Luan, Yinzai He, 中德临床肿瘤学杂志（英文版） . 2021,第004期

机译：Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma
3. Relationship between molecular changes in epidermal growth factor receptor(EGFR)and anaplastic lymphoma kinase(ALK)mutations in lung adenocarcinoma [J] . Rina Na, Wei Luan, Yinzai He, 肿瘤学与转化医学（英文） . 2021,第004期

机译：Relationship between molecular changes in epidermal growth factor receptor(EGFR)and anaplastic lymphoma kinase(ALK)mutations in lung adenocarcinoma
4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report [O] . Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, 2013

机译：对克唑替尼耐药的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变
7. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report [O] . Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, 2013

机译：对克唑替尼具有耐药性的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅